Both endogenous c-kit and CD44 are expressed in ovarian cancer cells and ovarian cancer tissues of patients and mice, and to be candidate cell surface markers for ovarian tumor progenitors[41]. This evidence concerns the gene CD44 and ovarian carcinoma.